Holdings
Eventide Healthcare & Life Sciences Fund
As of Jun 30, 2026, Eventide Healthcare & Life Sciences Fund reported 55 positions worth US$1.51B. Largest: Guardant Health, Inc., Mirum Pharmaceuticals, Inc. and Kymera Therapeutics, Inc. What it bought and sold, with each filing.
| Company | Shares | Value as reported | Change | As of |
|---|---|---|---|---|
| Guardant Health, Inc. | 640K | US$96.1M | −60,000 | Jun 30, 2026 |
| Mirum Pharmaceuticals, Inc. | 530K | US$62.1M | −161K | Jun 30, 2026 |
| Kymera Therapeutics, Inc. | 503K | US$57.7M | −123K | Jun 30, 2026 |
| Abivax Sa | 395K | US$52.6M | +74,471 | Jun 30, 2026 |
| Trevi Therapeutics, Inc. | 2.66M | US$49.6M | +37,694 | Jun 30, 2026 |
| Mbx Biosciences, Inc. | 873K | US$48.2M | −16,508 | Jun 30, 2026 |
| Vaxcyte, Inc. | 828K | US$48.1M | no change | Jun 30, 2026 |
| Cytokinetics, Incorporated | 564K | US$48M | +85,000 | Jun 30, 2026 |
| Argenx Se | 49,193 | US$45.6M | no change | Jun 30, 2026 |
| Ionis Pharmaceuticals, Inc. | 575K | US$45.6M | no change | Jun 30, 2026 |